Nooka, Ajay K.
Emory University,
United States
2025 Rank: 132438
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4016 out of 355674 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 132438 | 127279 |
| Total Cites | 1614 | 1890 |
| H-index | 18 | 19 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 0 | 0 |
| Number of Single+First Authored Papers | 37 | 37 |
| Total Cites to Single+First Authored Papers | 108 | 130 |
| Number of Single+First+Last Authored Papers | 59 | 59 |
| Total Cites to Single+First+Last Authored Papers | 162 | 187 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1074 | 1171 |
| Ratio of Total Citations to Distinct Citing Papers | 1.50 | 1.61 |
| Self-Citation Percentage |
14.60%
|
|
Nooka, Ajay K.
Emory University,
United States
2023 Rank: 91520
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 3274 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 91520 | 99829 |
| Total Cites | 1109 | 1291 |
| H-index | 18 | 18 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 32 | 32 |
| Total Cites to Single+First Authored Papers | 123 | 127 |
| Number of Single+First+Last Authored Papers | 49 | 49 |
| Total Cites to Single+First+Last Authored Papers | 178 | 186 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 808 | 886 |
| Ratio of Total Citations to Distinct Citing Papers | 1.37 | 1.46 |
| Self-Citation Percentage |
14.10%
|
|
Nooka, Ajay K.
Emory University,
United States
2022 Rank: 113042
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 4241 out of 293195 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 113042 | 120543 |
| Total Cites | 1046 | 1244 |
| H-index | 16 | 17 |
| Hm-index | 3 | 3 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 27 | 27 |
| Total Cites to Single+First Authored Papers | 114 | 118 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 152 | 166 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 774 | 864 |
| Ratio of Total Citations to Distinct Citing Papers | 1.35 | 1.44 |
| Self-Citation Percentage |
15.92%
|
|
Nooka, Ajay K.
Emory University,
United States
2021 Rank: 146426
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Immunology
Rank in SubField 1: 5263 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 146426 | 135867 |
| Total Cites | 1363 | 1645 |
| H-index | 17 | 19 |
| Hm-index | 4 | 4 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 24 | 24 |
| Total Cites to Single+First Authored Papers | 156 | 172 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 208 | 235 |
| Composite Score | 2 | 2 |
| Number of Distinct Citing Papers | 1029 | 1177 |
| Ratio of Total Citations to Distinct Citing Papers | 1.32 | 1.40 |
| Self-Citation Percentage |
17.14%
|
|
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.